Table 1.
Groups.
| Clinical and Echocardiographic Variables | Post-COVID-19 (N = 157) |
CTRL (N = 107) |
|---|---|---|
| Age (yrs) | 7.7 ± 4.5 | 11.0 ± 4.3 |
| Age range (yrs) | 0.3–18 | 0.3–18 |
| Female, n (%) | 62 (39) | 41 (38) |
| Body Surface Area (BSA) (m2) | 1.2 ± 0.4 | 1.3 ± 0.4 |
| LVEDD (mm) | 39.1 ± 6.7 | 40.7 ± 6.3 |
| LVEDD Z score | −0.33 ± 0.91 | −0.23 ± 0.75 |
| LVESD (mm) | 24.8 ± 4.7 | 26.2 ± 4.4 |
| LVESD Z score | −0.16 ± 1.06 | −0.15 ± 0.82 |
| LVEF (%) | 65.6 ± 4 | 65.0 ± 5 |
| LAVi (mL/m2) | 17.3 ± 6.4 | 17.7 ± 4.9 |
| TAPSE (mm) | 19.8 ±3.0 | 20.1 ±3.4 |
| E/A ratio | 1.9 ± 0.51 | 1.8 ± 0.51 |
| E/E’ avg, ratio | 5.9 ± 1.1 | 6.2 ± 1.3 |
Values are mean ± SD, or n (%). BSA: body surface area. LVEDD: left ventricular end diastolic diameter. LVESD: left ventricular end systolic diameter. LVEF: left ventricular ejection fraction. LAVi: left atrial volume indexed to BSA. TAPSE: tricuspid annular plane systolic excursion.